The Effect of Empagliflozin Versus Placebo on the Rate of Arrhythmic Events in Heart Failure Patients
Not yet recruiting
Phase of Trial: Phase IV
Latest Information Update: 30 Jan 2018
At a glance
- Drugs Empagliflozin (Primary)
- Indications Arrhythmias; Diabetes mellitus; Heart failure
- Focus Therapeutic Use
- 24 Jan 2018 Planned initiation date changed from 1 Nov 2017 to 15 Feb 2018.
- 07 Sep 2017 New trial record
- 06 Sep 2017 Planned initiation date changed from 1 Sep 2017 to 1 Nov 2017.